
六月 14, 2023
Renaissance BioScience’s novel RNAi biopesticide technology receives Canadian regulatory approval for 2023 field studies
Authorization from the PMRA, following a thorough review of the company’s extensive data dossier, indicates a mutual understanding of the composition, potential and low risk of the RNAi technology. Sponsored Content
Sponsored Content
Sponsored Content

十二月 03, 2022
Renaissance BioScience Corp adds Senior Executive Expertise to Push Commercialization of its RNA Production and Oral Delivery Platform Technology
Renaissance BioScience Corp., a leader in bioengineering for the global agriculture and food industries, has retained the services of S. Brad Griffith to assist Renaissance in commercializing its RNA production
十一月 18, 2022
New bill would allow PEI government to limit what crops can be grown in potato wart index fields
The minister of agriculture of Prince Edward Island (PEI), Canada has tabled legislation that would give the provincial government a lead role in trying to prevent the spread of potato wart in the province. Sponsored Content

十二月 03, 2021
Additional funding for Renaissance BioScience Corp's yeast-based RNA technology
Renaissance BioScience Corp., a leading global bioengineering company, announced today that it is receiving advisory services and additional funding of up to CAD 200,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).













